Código QR

Screening of selective histone deacetylase inhibitors by proteochemometric modeling

<p>Abstract</p> <p>Background</p> <p>Histone deacetylase (HDAC) is a novel target for the treatment of cancer and it can be classified into three classes, i.e., classes I, II, and IV. The inhibitors selectively targeting individual HDAC have been proved to be the better candidate antitumor drugs. To...

Descrición completa

Gardado en:
Principais autores: Wu Dingfeng, Huang Qi, Zhang Yida, Zhang Qingchen, Liu Qi, Gao Jun, Cao Zhiwei, Zhu Ruixin
Formato: Artigo
Idioma:Inglês
Publicado: BMC 2012-08-01
Series:BMC Bioinformatics
Assuntos:
Histone deacetylases inhibitors
Proteochemometric
Selective inhibitors
Acceso en liña:http://www.biomedcentral.com/1471-2105/13/212
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares